Quality assurance guidelines for interstitial hyperthermia

H. Dobšíček Trefná; M. Schmidt; G. C. van Rhoon; H. P. Kok; S. S. Gordeyev; U. Lamprecht; D. Marder; J. Nadobny; P. Ghadjar; S. Abdel-Rahman; A. M. Kukiełka; V. Strnad; M. D. Hurwitz; Z. Vujaskovic; C. J. Diederich; P. R. Stauffer; J. Crezee

doi:https://doi.org/10.1080/02656736.2018.1564155

Quality assurance guidelines for interstitial hyperthermia

H. Dobšíček Trefná, M. Schmidt, G. C. van Rhoon, H. P. Kok, S. S. Gordeyev, U. Lamprecht, D. Marder, J. Nadobny, P. Ghadjar, S. Abdel-Rahman, A. M. Kukiełka, V. Strnad, M. D. Hurwitz, Z. Vujaskovic, C. J. Diederich, P. R. Stauffer, J. Crezee

Research output: Contribution to journal › Article › Academic › peer-review

54 Citations (Scopus)

Abstract

Quality assurance (QA) guidelines are essential to provide uniform execution of clinical hyperthermia treatments and trials. This document outlines the clinical and technical consequences of the specific properties of interstitial heat delivery and specifies recommendations for hyperthermia administration with interstitial techniques. Interstitial hyperthermia aims at tumor temperatures in the 40–44 °C range as an adjunct to radiation or chemotherapy. The clinical part of this document imparts specific clinical experience of interstitial heat delivery to various tumor sites as well as recommended interstitial hyperthermia workflow and procedures. The second part describes technical requirements for quality assurance of current interstitial heating equipment including electromagnetic (radiative and capacitive) and ultrasound heating techniques. Detailed instructions are provided on characterization and documentation of the performance of interstitial hyperthermia applicators to achieve reproducible hyperthermia treatments of uniform high quality. Output power and consequent temperature rise are the key parameters for characterization of applicator performance in these QA guidelines. These characteristics determine the specific maximum tumor size and depth that can be heated adequately. The guidelines were developed by the ESHO Technical Committee with participation of senior STM members and members of the Atzelsberg Circle.

Original language	English
Pages (from-to)	277-294
Journal	International journal of hyperthermia
Volume	36
Issue number	1
DOIs	https://doi.org/10.1080/02656736.2018.1564155
Publication status	Published - 2019

Access to Document

https://doi.org/10.1080/02656736.2018.1564155

Cite this

Dobšíček Trefná, H., Schmidt, M., van Rhoon, G. C., Kok, H. P., Gordeyev, S. S., Lamprecht, U., Marder, D., Nadobny, J., Ghadjar, P., Abdel-Rahman, S., Kukiełka, A. M., Strnad, V., Hurwitz, M. D., Vujaskovic, Z., Diederich, C. J., Stauffer, P. R., & Crezee, J. (2019). Quality assurance guidelines for interstitial hyperthermia. International journal of hyperthermia, 36(1), 277-294. https://doi.org/10.1080/02656736.2018.1564155

@article{a8dd56fe69e8410ca9dfd365c1baf16c,

title = "Quality assurance guidelines for interstitial hyperthermia",

abstract = "Quality assurance (QA) guidelines are essential to provide uniform execution of clinical hyperthermia treatments and trials. This document outlines the clinical and technical consequences of the specific properties of interstitial heat delivery and specifies recommendations for hyperthermia administration with interstitial techniques. Interstitial hyperthermia aims at tumor temperatures in the 40–44 °C range as an adjunct to radiation or chemotherapy. The clinical part of this document imparts specific clinical experience of interstitial heat delivery to various tumor sites as well as recommended interstitial hyperthermia workflow and procedures. The second part describes technical requirements for quality assurance of current interstitial heating equipment including electromagnetic (radiative and capacitive) and ultrasound heating techniques. Detailed instructions are provided on characterization and documentation of the performance of interstitial hyperthermia applicators to achieve reproducible hyperthermia treatments of uniform high quality. Output power and consequent temperature rise are the key parameters for characterization of applicator performance in these QA guidelines. These characteristics determine the specific maximum tumor size and depth that can be heated adequately. The guidelines were developed by the ESHO Technical Committee with participation of senior STM members and members of the Atzelsberg Circle.",

author = "{Dob{\v s}{\'i}{\v c}ek Trefn{\'a}}, H. and M. Schmidt and {van Rhoon}, {G. C.} and Kok, {H. P.} and Gordeyev, {S. S.} and U. Lamprecht and D. Marder and J. Nadobny and P. Ghadjar and S. Abdel-Rahman and Kukie{\l}ka, {A. M.} and V. Strnad and Hurwitz, {M. D.} and Z. Vujaskovic and Diederich, {C. J.} and Stauffer, {P. R.} and J. Crezee",

year = "2019",

doi = "https://doi.org/10.1080/02656736.2018.1564155",

language = "English",

volume = "36",

pages = "277--294",

journal = "International journal of hyperthermia",

issn = "0265-6736",

publisher = "Informa Healthcare",

number = "1",

}

Dobšíček Trefná, H, Schmidt, M, van Rhoon, GC, Kok, HP, Gordeyev, SS, Lamprecht, U, Marder, D, Nadobny, J, Ghadjar, P, Abdel-Rahman, S, Kukiełka, AM, Strnad, V, Hurwitz, MD, Vujaskovic, Z, Diederich, CJ, Stauffer, PR & Crezee, J 2019, 'Quality assurance guidelines for interstitial hyperthermia', International journal of hyperthermia, vol. 36, no. 1, pp. 277-294. https://doi.org/10.1080/02656736.2018.1564155

TY - JOUR

T1 - Quality assurance guidelines for interstitial hyperthermia

AU - Dobšíček Trefná, H.

AU - Schmidt, M.

AU - van Rhoon, G. C.

AU - Kok, H. P.

AU - Gordeyev, S. S.

AU - Lamprecht, U.

AU - Marder, D.

AU - Nadobny, J.

AU - Ghadjar, P.

AU - Abdel-Rahman, S.

AU - Kukiełka, A. M.

AU - Strnad, V.

AU - Hurwitz, M. D.

AU - Vujaskovic, Z.

AU - Diederich, C. J.

AU - Stauffer, P. R.

AU - Crezee, J.

PY - 2019

Y1 - 2019

N2 - Quality assurance (QA) guidelines are essential to provide uniform execution of clinical hyperthermia treatments and trials. This document outlines the clinical and technical consequences of the specific properties of interstitial heat delivery and specifies recommendations for hyperthermia administration with interstitial techniques. Interstitial hyperthermia aims at tumor temperatures in the 40–44 °C range as an adjunct to radiation or chemotherapy. The clinical part of this document imparts specific clinical experience of interstitial heat delivery to various tumor sites as well as recommended interstitial hyperthermia workflow and procedures. The second part describes technical requirements for quality assurance of current interstitial heating equipment including electromagnetic (radiative and capacitive) and ultrasound heating techniques. Detailed instructions are provided on characterization and documentation of the performance of interstitial hyperthermia applicators to achieve reproducible hyperthermia treatments of uniform high quality. Output power and consequent temperature rise are the key parameters for characterization of applicator performance in these QA guidelines. These characteristics determine the specific maximum tumor size and depth that can be heated adequately. The guidelines were developed by the ESHO Technical Committee with participation of senior STM members and members of the Atzelsberg Circle.

AB - Quality assurance (QA) guidelines are essential to provide uniform execution of clinical hyperthermia treatments and trials. This document outlines the clinical and technical consequences of the specific properties of interstitial heat delivery and specifies recommendations for hyperthermia administration with interstitial techniques. Interstitial hyperthermia aims at tumor temperatures in the 40–44 °C range as an adjunct to radiation or chemotherapy. The clinical part of this document imparts specific clinical experience of interstitial heat delivery to various tumor sites as well as recommended interstitial hyperthermia workflow and procedures. The second part describes technical requirements for quality assurance of current interstitial heating equipment including electromagnetic (radiative and capacitive) and ultrasound heating techniques. Detailed instructions are provided on characterization and documentation of the performance of interstitial hyperthermia applicators to achieve reproducible hyperthermia treatments of uniform high quality. Output power and consequent temperature rise are the key parameters for characterization of applicator performance in these QA guidelines. These characteristics determine the specific maximum tumor size and depth that can be heated adequately. The guidelines were developed by the ESHO Technical Committee with participation of senior STM members and members of the Atzelsberg Circle.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85060648017&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30676101

U2 - https://doi.org/10.1080/02656736.2018.1564155

DO - https://doi.org/10.1080/02656736.2018.1564155

M3 - Article

C2 - 30676101

SN - 0265-6736

VL - 36

SP - 277

EP - 294

JO - International journal of hyperthermia

JF - International journal of hyperthermia

IS - 1

ER -

Quality assurance guidelines for interstitial hyperthermia

Abstract

Access to Document

Other files and links

Cite this